GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

By Dennis Thompson HealthDay ReporterTUESDAY, July 1, 2025 (HealthDay News) — Cookouts on the Fourth of July aren’t just a ...

These recent food recalls involve cream cheese, eggs, shrimp, and ice cream due to serious health risks including salmonella ...

A massive analysis recently published in the journal Aging Cell revealed that rapamycin — the immunosuppressant drug turned ...

Smucker's commits to remove artificial dyes from sugar-free fruit spreads, ice cream toppings and other products by 2027, ...

The Trump administration is continuing to make its imprint on U.S. vaccine policy in recent days. The moves could change what ...

News about Food and Drug Administration, including commentary and archival articles published in The New York Times.

Ibogaine is illegal in the U.S., but growing evidence shows its promise treating the effects of traumatic brain injury and ...

Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...

A fast-growing group of Americans are turning to what many call the "gray market" for obesity medicines, bringing cheap ...

News about Food and Drug Administration, including commentary and archival articles published in The New York Times.